Xencor, Inc.
Anti-CD39 antibodies and uses thereof
Last updated:
Abstract:
The present disclosure relates generally to anti-CD39 antibodies, including antibody-drug conjugates comprising the antibodies, and methods of their use.
Status:
Grant
Type:
Utility
Filling date:
6 Nov 2015
Issue date:
11 Feb 2020